Indicative Announcement on the Controlling Shareholder's Planning of Strategic Restructuring
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Indicative Announcement on the Controlling Shareholder's Planning of Strategic Restructuring
Filed with SSE · · 1 page · Chinese
Release
Hunan Nucien Pharmaceutical Co. Ltd. on 6ix
Earlier from Hunan Nucien Pharmaceutical
- Announcement on Changing Purpose of Repurchased Shares Canceling and Reducing Registered Capital, and Amending the "Articles of Association"
- Announcement on Resignation of Core Technical Personnel
- Announcement on Progress in Public Listing and Transfer of Partial Accounts Receivable
- Announcement on Progress in Repurchasing Shares through Call Auction
- Announcement on Preliminary Earnings Estimate for 2025
Later from Hunan Nucien Pharmaceutical
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Progress in Transfer of Partial Accounts Receivable and Related Party Transactions
- Announcement on Receiving the Prior Notice of Administrative Penalty
- Announcement on Voluntary Disclosure of Phase III Clinical Trial of Peramivir Inhalation Solution Reaching Prespecified Primary Endpoint
- Announcement on Obtaining Drug Registration Certificate for Levosalbutamol Hydrochloride Nebuliser Solution
Follow Hunan Nucien Pharmaceutical into a list and get an email when it puts out news.
Follow Hunan Nucien Pharmaceutical